M. Elisa Vink-Börger
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 6
- Peptidase Inhibition and Analysis 1
- Hepatology top 2%
-
- Genetic factors in colorectal cancer 4
- Cancer Mechanisms and Therapy 1
- Cancer Research top 5%
-
- Gastric Cancer Management and Outcomes 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Veterinary medicine and infectious diseases 1
-
- Gastrointestinal Tumor Research and Treatment 1
- Co-authors
- Cornelis J.A. PuntJ. Han van KriekenJeroen R. DijkstraJolien TolMiriam KoopmanIrıs D. NagtegaalD. J. RichelC. J. Rodenburg
- Journals
- British Journal of Cancer (1 paper)Orphanet Journal of Rare Diseases (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- NetherlandsUnited States
In The Last Decade
M. Elisa Vink-Börger
9 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 1.3k
- Hepatology 354
- Pathology and Forensic Medicine 487
- Cancer Research 340
- Pulmonary and Respiratory Medicine 535
Countries citing papers authored by M. Elisa Vink-Börger
This map shows the geographic impact of M. Elisa Vink-Börger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Elisa Vink-Börger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Elisa Vink-Börger more than expected).
Fields of papers citing papers by M. Elisa Vink-Börger
This network shows the impact of papers produced by M. Elisa Vink-Börger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Elisa Vink-Börger. The network helps show where M. Elisa Vink-Börger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Elisa Vink-Börger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 15 | |
| 2 | 2013 | 18 | |
| 3 | 2012 | 16 | |
| 4 | 2012 | 55 | |
| 5 | 2011 | 235 | |
| 6 | 2010 | 174 | |
| 7 | 2009 | 70 | |
| 8 | Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancerbreakdown → | 2009 | 1004 |
| 9 | 2009 | 9 |
About M. Elisa Vink-Börger
M. Elisa Vink-Börger is a scholar working on Pathology and Forensic Medicine, Oncology, Gastroenterology, Small Animals and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 1.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Genetic factors in colorectal cancer (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Cancer Mechanisms and Therapy (1 paper), Peptidase Inhibition and Analysis (1 paper), Veterinary medicine and infectious diseases (1 paper) and Gastrointestinal Tumor Research and Treatment (1 paper). The work is most often cited by research in Oncology (1.3k citations), Hepatology (354 citations), Pathology and Forensic Medicine (487 citations), Cancer Research (340 citations) and Pulmonary and Respiratory Medicine (535 citations). M. Elisa Vink-Börger has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Cornelis J.A. Punt, J. Han van Krieken, Jeroen R. Dijkstra, Jolien Tol, Miriam Koopman, Irıs D. Nagtegaal, D. J. Richel, C. J. Rodenburg, Cees J. van Groeningen and Harm Sinnige. Their work appears in journals such as British Journal of Cancer, Orphanet Journal of Rare Diseases, New England Journal of Medicine, Gut and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.